Gainers
- Prothena Corporation plc (NASDAQ:PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative diseases, like Alzheimer’s.
- Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares gained 72.1% to $8.09 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
- PepGen Inc. (NASDAQ:PEPG) gained 70% to $8.86 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
- bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 63.7% to $3.47 after the company announced it received an additional $7.7 million from the exercise of warrants.
- BTRS Holdings Inc. (NASDAQ:BTRS) climbed 59.5% to $9.20. The EQT X fund agreed to acquire BTRS Holdings, a B2B accounts receivable automation and integrated payments company, in an all-cash transaction valuing Billtrust's equity at $1.7 billion.
- Atlis Motor Vehicles Inc (NASDAQ:AMV) rose 54.7% to $127.00 after jumping around 199% on Tuesday.
- Biogen Inc. (NASDAQ:BIIB) shares rose 35.3% to $267.60. Biogen and Eisai Co. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.
- SOBR Safe, Inc. (NASDAQ:SOBR) gained 29.6% to $1.75 after the company announced its SOBRcheck is replacing breathalyzers in the American judicial system.
- Top Ships Inc. (NASDAQ:TOPS) climbed 28% to $3.0046 after the company announced 1H FY22 revenue of $38.8 million, which is up 53% year over year.
- FingerMotion, Inc. (NASDAQ:FNGR) gained 23.3% to $1.32.
- Quanterix Corporation (NASDAQ:QTRX) rose 22.2% to $9.86.
- ProMIS Neurosciences, Inc. (NASDAQ:PMN) gained 22.2% to $6.10.
- MorphoSys AG (NASDAQ:MOR) rose 20% to $5.34.
- Aspen Group, Inc. (NASDAQ:ASPU) surged 19.7% to $0.3949. Aspen Group Director Douglas Kass acquired a total of 61,500 shares at an average price of $0.42.
- Denali Therapeutics Inc. (NASDAQ:DNLI) gained 19.6% to $32.65.
- KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) gained 19.4% to $6.39. KLX Energy Services raised Q3 sequential revenue growth from 9%-13% to 16%-18% and adjusted EBITDA from 10%-12% to 14%-16%.
- Neuronetics, Inc. (NASDAQ:STIM) gained 19.3% to $2.84.
- Nano-X Imaging Ltd. (NASDAQ:NNOX) gained 18.3% to $12.03. Nano X Imaging, last month, posted a Q2 loss of $0.16 per share.
- AC Immune SA (NASDAQ:ACIU) gained 18.2% to $2.98. Shares of companies with Alzheimer's programs traded higher after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.
- Invitae Corporation (NYSE:NVTA) climbed 18% to $2.7850.
- RadNet, Inc. (NASDAQ:RDNT) gained 17.7% to $21.13.
- Mondee Holdings, Inc. (NASDAQ:MOND) rose 17.6% to $10.37.
- Janux Therapeutics, Inc. (NASDAQ:JANX) jumped 17% to $14.97.
- Good Times Restaurants Inc. (NASDAQ:GTIM) gained 16.4% to $2.5899.
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) surged 14.5% to $3.30.
- Janux Therapeutics, Inc. (NASDAQ:JANX) gained 14.3% to $14.62.
- Coeur Mining, Inc. (NYSE:CDE) jumped 13% to $3.20.
- Pacific Biosciences of California, Inc. (NASDAQ:PACB) gained 12% to $5.89.
- Peabody Energy Corporation (NYSE:BTU) surged 10.7% to $24.65.
- Silo Pharma, Inc. (NASDAQ:SILO) rose 9.4% to $5.53 following uplisting to the Nasdaq.
- Lilly and Company (NYSE:LLY) rose 8.7% to $338.31. Shares of companies with potential Alzheimer's treatments traded higher in sympathy with Biogen.
- Yamana Gold Inc. (NYSE:AUY) gained 8.4% to $4.3450.
